Related by context. Frequent words. (Click for all words.) 53 Suven Life Sciences 53 Par Pharmaceutical Companies 53 Ranbaxy Laboratories Limited 51 UCB Pharma 51 GlaxoSmithKline Pharmaceuticals 51 Elder Pharmaceuticals 51 NYSE RDY 51 Otsuka Pharmaceutical 50 Cadila Healthcare 50 NYSE MYL 49 Dr Reddys Laboratories 49 Elder Pharma 48 Barr Laboratories Inc. 48 Abbreviated New 48 Panacea Biotec 48 Mylan Pharmaceuticals Inc. 48 Paladin Labs 48 Otsuka Pharmaceutical Co. 48 Sankyo Co. 47 Aventis Pharma 47 Nicholas Piramal India 47 Venus Remedies 47 Dr. Reddy Laboratories 47 Oscient Pharmaceuticals 47 Aurobindo Pharma 47 Shasun 47 Sun Pharmaceutical Industries 47 Zydus Cadila 46 Shasun Chemicals 46 Glenmark Pharmaceuticals 46 Torrent Pharma 46 Aventis Pharmaceuticals 46 Strides Arcolab 46 Ranbaxy Laboratories Ltd 46 Zydus 46 Janssen Pharmaceutica NV 46 maker Ranbaxy Laboratories 46 Panacea Biotech 46 Crofelemer 46 Ind Swift 45 Biocon Ltd 45 Ortho McNeil Janssen 45 Phosphagenics 45 Taro Pharmaceutical Industries 45 Sabinsa 45 Solodyn 45 Glenmark Pharma 45 Drug Administration USFDA 44 Dabur Pharma 44 Suven 44 Jubilant Organosys 44 Kyowa Hakko Kirin 44 Bionomics 44 Durect 44 Intellipharmaceutics 44 RDY 44 Dr Reddy Laboratories 44 Bristol Myers Squibb BMS 44 Teva Pharmaceuticals USA 44 Forest Laboratories 44 Paragraph IV 43 Par Pharmaceutical 43 Bharat Biotech 43 Novartis Pharma 43 Biochem 43 Natco Pharma 43 Sinclair Pharma 43 ANDAs 43 Collaboration Agreement 43 Daiichi Sankyo Co. 43 Eisai 43 Impax Laboratories Inc. 43 RLL 43 Lupin 42 Abbott Molecular 42 Gabapentin 42 Citizen Petition 42 Ondansetron 42 Chugai Pharmaceutical Co. 42 Symyx Technologies 42 BioAlliance 42 Daiichi Sankyo 42 MOSAID Technologies Inc. 42 TAP Pharmaceutical Products 42 GVK BIO 42 Patent Litigation 42 Matrix Laboratories 42 BioSciences 42 Pharmaceuticals 42 Cipla 42 Transition Therapeutics 41 Depomed 41 AAIPharma 41 generic injectable 41 Mitsubishi Pharma 41 Ranbaxy Laboratories 41 Dishman Pharma 41 Patent Infringement 41 Paragraph IV certification 41 ANDA 41 Strategic Diagnostics